Vorasidenib in CNS WHO Grade 2 IDH-mutant Diffuse Glioma
Vorasidenib in CNS WHO Grade 2 IDH-mutant Diffuse Glioma
Recruiting · NCT07240662 · Registry updated 2026-01-09Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Vorasidenib in CNS WHO Grade 2 IDH-mutant Diffuse Glioma | Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, epithelial neoplasm, glioma, neoplasm, neuroepithelial neoplasm, primitive neuroectodermal tumor | Recruiting | Not stated | 2026-01-09 | NCT07240662 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| iOMEDICO AG | 19 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Nationales Centrum für Tumorerkrankungen (NCT) Heidelberg | Heidelberg | Germany | 2 |